Synaptic protein deficits are associated with dementia irrespective of extreme old age

Neurobiology of Aging

Volumn 33, Issue 6, 2012, Pages 1125.e1-1125.e8

  Schnaider Beeri, Michal ^a   Haroutunian, Vahram ^a,b   Schmeidler, James ^a   Sano, Mary ^a,b   Fam, Peter ^a   Kavanaugh, Aaron ^a   Barr, Alasdair M ^c   Honer, William G ^c   Katsel, Pavel ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Aging; Alzheimer's disease; Gene expression; Protein expression; Synaptic proteins

Indexed keywords

MESSENGER RNA; SYNAPTOBREVIN; SYNAPTOPHYSIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; SYNTAXIN;

AGING; ANTIBODY SPECIFICITY; ARTICLE; B2M GENE; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; GENE EXPRESSION; GENETIC ASSOCIATION; GUSB GENE; HOUSEKEEPING GENE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NEUROTRANSMISSION; NUCLEOTIDE SEQUENCE; PGK1 GENE; PPIA GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SENILE PLAQUE; SYNAPSE;

EID: 84859487793     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.08.017     Document Type: Article

References (51)

1. Akram A., Christoffel D., Rocher A.B., Bouras C., Kövari E., Perl D.P., Morrison J.H., Herrmann F.R., Haroutunian V., Giannakopoulos P., Hof P.R. Stereologic estimates of total spinophilin-immunoreactive spine number in area 9 and the CA1 field: relationship with the progression of Alzheimer's disease. Neurobiol. Aging 2008, 29:1296-1307.
2. Barakauskas V.E., Beasley C.L., Barr A.M., Ypsilanti A.R., Li H.Y., Thornton A.E., Wong H., Rosokilja G., Mann J.J., Mancevski B., Jakovski Z., Davceva N., Ilievski B., Dwork A.J., Falkai P., Honer W.G. A novel mechanism and treatment target for presynaptic abnormalities in specific striatal regions in schizophrenia. Neuropsychopharmacology 2010, 35:1226-1238.
3. Barr A.M., Young C.E., Sawada K., Trimble W.S., Phillips A.G., Honer W.G. Abnormalities of presynaptic protein CDCrel-1 in striatum of rats reared in social isolation: relevance to neural connectivity in schizophrenia. Eur. J. Neurosci 2004, 20:303-307.
4. Brown D.F., Risser R.C., Bigio E.H., Tripp P., Stiegler A., Welch E., Eagan K.P., Hladik C.L., White C.L. Neocortical synapse density and Braak stage in the Lewy body variant of Alzheimer disease: a comparison with classic Alzheimer disease and normal aging. J. Neuropathol. Exp. Neurol 1998, 57:955-960.
5. Butterworth J., Tennant M.C. Postmortem human brain pH and lactate in sudden infant death syndrome. J. Neurochem 1989, 53:1494-1499.
6. Corrada M.M., Brookmeyer R., Paganini-Hill A., Berlau D., Kawas C.H. Dementia incidence continues to increase with age in the oldest old: the 90+ study. Ann. Neurol 2010, 67:114-121.
7. Davis K.L., Mohs R.C., Marin D., Purohit D.P., Perl D.P., Lantz M., Austin G., Haroutunian V. Cholinergic markers in elderly patients with early signs of Alzheimer disease. JAMA 1999, 281:1401-1406.
8. Dekosky S.T., Scheff S.W. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol 1990, 27:457-464.
9. Dracheva S., McGurk S.R., Haroutunian V. mRNA expression of AMPA receptors and AMPA receptor binding proteins in the cerebral cortex of elderly schizophrenics. J. Neurosci. Res 2005, 79:868-878.
10. Engelhart M.J., Geerlings M.I., Meijer J., Kiliaan A., Ruitenberg A., van Swieten J.C., Stijnen T., Hofman A., Witteman J.C., Breteler M.M. Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. Arch. Neurol 2004, 61:668-672.
11. Evans D.A., Funkenstein H.H., Albert M.S., Scherr P.A., Cook N.R., Chown M.J., Hebert L.E., Hennekens C.H., Taylor J.O. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA 1989, 262:2551-2556.
12. Forero D.A., Casadesus G., Perry G., Arboleda H. Synaptic dysfunction and oxidative stress in Alzheimer's disease: emerging mechanisms. J. Cell. Mol. Med 2006, 10:796-805.
13. Haley G.E., Kohama S.G., Urbanski H.F., Raber J. Age-related decreases in SYN levels associated with increases in MAP-2, apoE, and GFAP levels in the rhesus macaque prefrontal cortex and hippocampus. Age (Dordr) 2010, 32:283-296.
14. Haroutunian V., Katsel P., Dracheva S., Davis K.L. The human homolog of the QKI gene affected in the severe dysmyelination "quaking" mouse phenotype: downregulated in multiple brain regions in schizophrenia. Am. J. Psychiatry 2006, 163:1834-1837.
15. Haroutunian V., Perl D.P., Purohit D.P., Marin D., Khan K., Lantz M., Davis K.L., Mohs R.C. Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. Arch. Neurol 1998, 55:1185-1191.
16. Haroutunian V., Purohit D.P., Perl D.P., Marin D., Khan K., Lantz M., Davis K.L., Mohs R.C. Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease. Arch. Neurol 1999, 56:713-718.
17. Haroutunian V., Schnaider-Beeri M., Schmeidler J., Wysocki M., Purohit D.P., Perl D.P., Libow L.S., Lesser G.T., Maroukian M., Grossman H.T. Role of the neuropathology of Alzheimer disease in dementia in the oldest-old. Arch. Neurol 2008, 65:1211-1217.
18. Haroutunian V., Serby M., Purohit D.P., Perl D.P., Marin D., Lantz M., Mohs R.C., Davis K.L. Contribution of Lewy body inclusions to dementia in patients with and without Alzheimer disease neuropathological conditions. Arch. Neurol 2000, 57:1145-1150.
19. He W., Sengupta M., Velkoff V.A., Debarros J.A. 65+ in the United States: current population reports, special studies 2005, 23-209. Department of Health Services and Department of Commerce, Washington, DC.
20. Head E., Corrada M.M., Kahle-Wrobleski K., Kim R.C., Sarsoza F., Goodus M., Kawas C.H. Synaptic proteins, neuropathology and cognitive status in the oldest-old. Neurobiol. Aging 2009, 30:1125-1134.
21. Heffernan J.M., Eastwood S.L., Nagy Z., Sanders M.W., McDonald B., Harrison P.J. Temporal cortex synaptophysin mRNA is reduced in Alzheimer's disease and is negatively correlated with the severity of dementia. Exp. Neurol 1998, 150:235-239.
22. Honer W.G. Pathology of presynaptic proteins in Alzheimer's disease: more than simple loss of terminals. Neurobiol. Aging 2003, 24:1047-1062.
23. Honer W.G., Falkai P., Bayer T.A., Xie J., Hu L., Li H.Y., Arango V., Mann J.J., Dwork A.J., Trimble W.S. Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness. Cereb. Cortex 2002, 12:349-356.
24. Katsel P., Tan W., Haroutunian V. Gain in brain immunity in the oldest-old differentiates cognitively normal from demented individuals. PLoS One 2009, 4(10):e7642.
25. Masliah E., Crews L., Hansen L. Synaptic remodeling during aging and in Alzheimer's disease. J. Alzheimers. Dis 2006, 9:91-99.
26. Masliah E., Mallory M., Hansen L., DeTeresa R., Terry R.D. Quantitative synaptic alterations in the human neocortex during normal aging. Neurology 1993, 43:192-197.
27. Mattson M.P., Liu D. Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders. Neuromolecular Med 2002, 2:215-231.
28. McDonald C.R., McEvoy L.K., Gharapetian L., Fennema-Notestine C., Hagler D.J., Holland D., Koyama A., Brewer J.B., Dale A.M. Regional rates of neocortical atrophy from normal aging to early Alzheimer disease. Neurology 2009, 73:457-465. Alzheimer's Disease Neuroimaging Initiative.
29. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991, 41:479-486.
30. Morris J.C., Ernesto C., Schafer K., Coats M., Leon S., Sano M., Thal L.J., Woodbury P. Clinical dementia rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experience. Neurology 1997, 48:1508-1510.
31. Mucke L., Masliah E., Yu G.Q., Mallory M., Rockenstein E.M., Tatsuno G., Hu K., Kholodenko D., Johnson-Wood K., McConlogue L. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci 2000, 20:4050-4058.
32. Pham E., Crews L., Ubhi K., Hansen L., Adame A., Cartier A., Salmon D., Galasko D., Michael S., Savas J.N., Yates J.R., Glabe C., Masliah E. Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins. FEBS J 2010, 277:3051-3067.
33. Prohovnik I., Perl D.P., Davis K.L., Libow L., Lesser G., Haroutunian V. Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease. Neurology 2006, 66:49-55.
34. Rizo J., Rosenmund C. Synaptic vesicle fusion. Nat. Struct. Mol. Biol 2008, 15:665-674.
35. Savva G.M., Wharton S.B., Ince P.G., Forster G., Matthews F.E., Brayne C. Age, neuropathology, and dementia. N. Engl. J. Med 2009, 360:2302-2309. Medical Research Council Cognitive Function and Ageing Study.
36. Sawada K., Young C.E., Barr A.M., Longworth K., Takahashi S., Arango V., Mann J.J., Dwork A.J., Falkai P., Phillips A.G., Honer W.G. Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illness. Mol. Psychiatry 2002, 7:484-492.
37. Scheff S.W., Price D.A., Schmitt F.A., Dekosky S.T., Mufson E.J. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 2007, 68:1501-1508.
38. Schnaider Beeri M., Goldbourt U., Silverman J.M., Noy S., Schmeidler J., Ravona-Springer R., Sverdlick A., Davidson M. Diabetes mellitus in midlife and the risk of dementia three decades later. Neurology 2004, 63:1902-1907.
39. Selkoe D.J. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav. Brain Res 2008, 192:106-113.
40. Seltzer B., Pandya D.N. Afferent cortical connections and architectonics of the superior temporal sulcus and surrounding cortex in the rhesus monkey. Brain Res 1978, 149:1-24.
41. Serby M., Brickman A.M., Haroutunian V., Purohit D.P., Marin D., Lantz M., Mohs R.C., Davis K.L. Cognitive burden and excess Lewy-body pathology in the Lewy-body variant of Alzheimer disease. Am. J. Geriatr. Psychiatry 2003, 11:371-374.
42. Shankar G.M., Li S., Mehta T.H., Garcia-Munoz A., Shepardson N.E., Smith I., Brett F.M., Farrell M.A., Rowan M.J., Lemere C.A., Regan C.M., Walsh D.M., Sabatini B.L., Selkoe D.J. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med 2008, 14:837-842.
43. Silverman J.M., Beeri M.S., Schmeidler J., Rosendorff C., Angelo G., Mavris R.S., Grossman H.T., Elder G.A., Carrion-Baralt J., West R. c. reactive protein and memory function suggest antagonistic pleiotropy in very old nondemented subjects. Age Ageing 2009, 38:237-241.
44. Skoog I., Lernfelt B., Landahl S., Palmertz B., Andreasson L.A., Nilsson L., Persson G., Odén A., Svanborg A. 15-year longitudinal study of blood pressure and dementia. Lancet 1996, 347:1141-1145.
45. Stern Y., Zarahn E., Habeck C., Holtzer R., Rakitin B.C., Kumar A., Flynn J., Steffener J., Brown T. A common neural network for cognitive reserve in verbal and object working memory in young but not old. Cereb. Cortex 2008, 18:959-967.
46. Südhof T.C., Rothman J.E. Membrane fusion: grappling with SNARE and SM proteins. Science 2009, 323:474-477.
47. Percent Distribution of the Projected Population by Selected Age Groups and Sex for the United States: 2010 to 2050 U.S. Census Bureau. http://www.census.gov/population/www/projections/summarytables.html.
48. Ubhi K., Peng K., Lessig S., Estrella J., Adame A., Galasko D., Salmon D.P., Hansen L.A., Kawas C.H., Masliah E. Neuropathology of dementia with Lewy bodies in advanced age: a comparison with Alzheimer disease. Neurosci. Lett 2010, 485:222-227.
49. VanGuilder H.D., Yan H., Farley J.A., Sonntag W.E., Freeman W.M. Aging alters the expression of neurotransmission-regulating proteins in the hippocampal synaptoproteome. J. Neurochem 2010, 113:1577-1588.
50. West R., Beeri M.S., Schmeidler J., Hannigan C.M., Angelo G., Grossman H.T., Rosendorff C., Silverman J.M. Better memory functioning associated with higher total and low-density lipoprotein cholesterol levels in very elderly subjects without the apolipoprotein e4 allele. Am. J. Geriatr. Psychiatry 2008, 16:781-785.
51. Zhang C., Wu B., Beglopoulos V., Wines-Samuelson M., Zhang D., Dragatsis I., Südhof T.C., Shen J. Presenilins are essential for regulating neurotransmitter release. Nature 2009, 460:632-636.